KILITCH Q1 FY27 results at a glance
KILITCH DRUGS INDIA LTD Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹44.88 cr |
|---|
| Revenue YoY | +4.0% |
|---|
| Operating profit | ₹1.84 cr |
|---|
| Operating margin | 4.1% |
|---|
| Net profit | ₹2.91 cr |
|---|
| Net profit YoY | -3.7% |
|---|
| Net profit QoQ | -79.9% |
|---|
| Net margin | 6.5% |
|---|
| Basic EPS | ₹0.83 |
|---|
| TTM revenue | ₹237 cr |
|---|
| TTM net profit | ₹30.05 cr |
|---|
| TTM net margin | 12.7% |
|---|
KILITCH Q1 FY27 results: what the numbers say
KILITCH DRUGS INDIA LTD (KILITCH) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹44.88 cr and a net profit of ₹2.91 cr, translating into earnings per share of ₹0.83.
Compared with the same quarter a year earlier, revenue grew by +4.0% and net profit declined by -3.7%. Profit trailing revenue growth suggests costs, interest or tax absorbed part of the topline gain.
Operating profit for the quarter stood at ₹1.84 cr, an operating margin of 4.1% versus 5.6% a year ago — a contraction of 1.5 percentage points.
KILITCH quarter-wise results table
Revenue
₹44.88 cr
+4.0% YoY
Net profit
₹2.91 cr
-3.7% YoY
Operating profit
₹1.84 cr
-23.9% YoY
KILITCH DRUGS INDIA LTD (KILITCH) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹44.88 cr | ₹1.84 cr | ₹2.91 cr | 4.1% | 6.5% | ₹0.83 | -3.7% | -79.9% |
| Q4 FY262026-03-31 | ₹89.6 cr | ₹21.16 cr | ₹14.52 cr | 23.6% | 16.2% | ₹4.24 | — | +227.6% |
| Q3 FY262025-12-31 | ₹53.81 cr | ₹5.21 cr | ₹4.43 cr | 9.7% | 8.2% | ₹1.25 | — | -45.9% |
| Q2 FY262025-09-30 | ₹48.92 cr | ₹4.18 cr | ₹8.19 cr | 8.5% | 16.7% | ₹2.48 | — | +170.7% |
| Q1 FY262025-06-30 | ₹43.14 cr | ₹2.42 cr | ₹3.03 cr | 5.6% | 7.0% | ₹0.94 | — | — |
| TTM (last 4 quarters) | ₹237 cr | ₹32.4 cr | ₹30.05 cr | 13.7% | 12.7% | ₹8.80 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
KILITCH quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
KILITCH DRUGS INDIA LTD quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹44.88 cr | ₹89.6 cr | ₹53.81 cr | ₹48.92 cr | ₹43.14 cr |
|---|
| Total expenses | ₹43.04 cr | ₹68.44 cr | ₹48.59 cr | ₹44.75 cr | ₹40.72 cr |
|---|
| Gross profit | ₹21.16 cr | ₹45.45 cr | ₹22.92 cr | ₹22.56 cr | ₹17.68 cr |
|---|
| Operating profit (EBIT) | ₹1.84 cr | ₹21.16 cr | ₹5.21 cr | ₹4.18 cr | ₹2.42 cr |
|---|
| Operating margin | 4.1% | 23.6% | 9.7% | 8.5% | 5.6% |
|---|
| Interest cost | ₹0.88 cr | ₹1.44 cr | ₹1.15 cr | ₹1.44 cr | ₹1.53 cr |
|---|
| Profit before tax | ₹3.86 cr | ₹20.21 cr | ₹5.6 cr | ₹9.4 cr | ₹3.45 cr |
|---|
| Tax expense | ₹1.9 cr | ₹5.33 cr | ₹1.28 cr | ₹1.36 cr | ₹1.19 cr |
|---|
| Effective tax rate | 49.1% | 26.4% | 22.9% | 14.5% | 34.4% |
|---|
| Net profit (PAT) | ₹2.91 cr | ₹14.52 cr | ₹4.43 cr | ₹8.19 cr | ₹3.03 cr |
|---|
| Net profit margin | 6.5% | 16.2% | 8.2% | 16.7% | 7.0% |
|---|
| Basic EPS | ₹0.83 | ₹4.24 | ₹1.25 | ₹2.48 | ₹0.94 |
|---|
| Diluted EPS | ₹0.83 | ₹4.24 | ₹1.25 | ₹2.48 | ₹0.94 |
|---|
KILITCH results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +4.0% | — | — | — | — |
|---|
| Revenue QoQ | -49.9% | +66.5% | +10.0% | +13.4% | — |
|---|
| Operating profit YoY | -23.9% | — | — | — | — |
|---|
| Operating profit QoQ | -91.3% | +305.8% | +24.8% | +72.6% | — |
|---|
| Net profit YoY | -3.7% | — | — | — | — |
|---|
| Net profit QoQ | -79.9% | +227.6% | -45.9% | +170.7% | — |
|---|
| EPS YoY | -11.7% | — | — | — | — |
|---|
| EPS QoQ | -80.4% | +239.2% | -49.7% | +164.4% | — |
|---|
KILITCH annual results history
Full-year performance for KILITCH DRUGS INDIA LTD, useful for reading each quarter in context.
KILITCH DRUGS INDIA LTD annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹235 cr | ₹197 cr | ₹154 cr | ₹139 cr |
|---|
| Total expenses | ₹201 cr | ₹169 cr | ₹133 cr | ₹125 cr |
|---|
| Gross profit | ₹106 cr | ₹90.49 cr | ₹73.14 cr | ₹61.72 cr |
|---|
| Operating profit (EBIT) | ₹34.16 cr | ₹28.63 cr | ₹21.08 cr | ₹14.35 cr |
|---|
| Operating margin | 14.5% | 14.5% | 13.7% | 10.3% |
|---|
| Interest cost | ₹5.56 cr | ₹5.04 cr | ₹5.93 cr | ₹4.92 cr |
|---|
| Profit before tax | ₹38.65 cr | ₹34.47 cr | ₹19.35 cr | ₹12.01 cr |
|---|
| Tax expense | ₹9.15 cr | ₹9.53 cr | ₹5.78 cr | ₹3.73 cr |
|---|
| Effective tax rate | 23.7% | 27.7% | 29.9% | 31.1% |
|---|
| Net profit (PAT) | ₹30.17 cr | ₹26.7 cr | ₹14.6 cr | ₹10.45 cr |
|---|
| Net profit margin | 12.8% | 13.5% | 9.5% | 7.5% |
|---|
| Basic EPS | ₹8.91 | ₹8.12 | ₹4.49 | ₹3.28 |
|---|
| Diluted EPS | ₹8.91 | ₹8.12 | ₹4.49 | ₹3.28 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹44.88 cr against ₹43.14 cr in Q1 FY26, and ₹89.6 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue declined -49.9%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹43.04 cr, or 95.9% of revenue, with operating profit declined -23.9% year on year.
Margins, tax and profitability
Net profit of ₹2.91 cr works out to a net margin of 6.5% compared with 7.0% in the year-ago quarter. Margin pressure of this kind usually reflects higher input costs, pricing competition, or a heavier interest and depreciation load.
Below the operating line, KILITCH DRUGS INDIA LTD reported profit before tax of ₹3.86 cr, a tax charge of ₹1.9 cr (effective rate 49.1%), interest cost of ₹0.88 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹14.52 cr in Q4 FY26 to ₹2.91 cr in Q1 FY27, a change of -79.9%.
Trailing twelve months and annual context
Across the trailing four quarters KILITCH DRUGS INDIA LTD has generated revenue of ₹237 cr and net profit of ₹30.05 cr, a trailing net margin of 12.7%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹235 cr with net profit of ₹30.17 cr and EPS of ₹8.91, versus the prior year where revenue grew +19.3% and profit grew +13.0%.
What to watch in the next KILITCH quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A single weak quarter matters less than the direction over three to four consecutive quarters.
KILITCH DRUGS INDIA LTD has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
KILITCH results coverage
No results report published for KILITCH yet — our desk covers each quarter within minutes of the filing.
KILITCH quarterly results FAQs
What were KILITCH DRUGS INDIA LTD (KILITCH) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), KILITCH DRUGS INDIA LTD reported revenue of ₹44.88 cr and net profit of ₹2.91 cr, a change of -3.7% year on year on +4.0% revenue growth. EPS stood at ₹0.83.
What is KILITCH profit margin in Q1 FY27?
KILITCH DRUGS INDIA LTD posted a net profit margin of 6.5% and an operating margin of 4.1% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹237 cr and net profit ₹30.05 cr.
Did KILITCH results beat the previous quarter?
KILITCH DRUGS INDIA LTD net profit changed -79.9% quarter on quarter, from ₹14.52 cr in Q4 FY26 to ₹2.91 cr in Q1 FY27.
When are KILITCH DRUGS INDIA LTD (KILITCH) quarterly results?
KILITCH DRUGS INDIA LTD has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see KILITCH latest quarterly results?
Results coverage for KILITCH will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the KILITCH stock page.
What is KILITCH DRUGS INDIA LTD annual revenue and profit?
For FY26, KILITCH DRUGS INDIA LTD reported full-year revenue of ₹235 cr and net profit of ₹30.17 cr, with EPS of ₹8.91.
How many quarterly results has KILITCH declared recently?
Past results dates for KILITCH will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 11 Sept 2026. For information only, not investment advice.
